Dr. Scott M. Acker, MD

Dr. Acker practices at Douglas Dermatology and Skin Cancer Specialists in Columbus, Georgia.

Dr. Acker's NPI, 1639158389, was assigned on January 11, 2006. Dr. Acker graduated from Frederick P. Whiddon College of Medicine in 1994. Dr. Acker's Alabama license number on file is 24371.

Dr. Acker's primary practice is Douglas Dermatology and Skin Cancer Specialists, at 400 Brookstone Centre Pkwy, Columbus, GA 31904 in Muscogee County. The practice phone is (678) 702-3376.

Dr. Acker's primary practice is Douglas Dermatology and Skin Cancer Specialists in Columbus, Georgia. The medical group on file is Douglas Dermatology Skin Cancer Specialists. Dmand AI also links Dr. Acker to 3 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Acker practices, 3 sites in all. Vendor and product names are available with a free account.

Pathology is Dr. Acker's primary specialty in the NPI Registry, under taxonomy code 207ZD0900X. The record also lists dermatopathology. Dr. Acker is board certified in anatomic pathology by the American Board of Pathology. Dmand AI has Dr. Acker's licenses on file in 15 states: Alabama, California, Colorado, Delaware, Florida, Georgia, Massachusetts, New Jersey, New York, Ohio, South Carolina, Arizona, Illinois, Kentucky and Louisiana.

CMS data shows 113,716 Medicare services from Dr. Acker across 26 procedure codes in 2024, for 26,479 Medicare patients. Medicare paid $3,494,508 for them. Every service was in an office.

CMS counts 26,479 Medicare patients who saw Dr. Acker in 2024. The largest group is 65 to 74, with 10,989 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Acker's median patient age at 74, with 53% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Acker for performance year 2024, reported individually. Dr. Acker accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Acker in 2008. The most frequent topics are Skin Neoplasms and Diagnosis, Differential. Dr. Acker has published most often in Am J Dermatopathol. Dr. Acker's most frequent co-authors are Chung Che Chang, MD, Emily Y. Chu, MD and Rosalie Elenitsas, MD.

Dmand AI links Dr. Acker to 4 clinical trials. 4 are still active or recruiting. Conditions studied include Breast Neoplasms, Carcinoma, Non-Small-Cell Lung and Prostatic Neoplasms. Proton Collaborative Group sponsors the most, 4.

CMS Open Payments shows 1 general payment to Dr. Acker from 1 drug or device company in 2017. Food and beverage make up the largest share, 100% of the total. Roche Diagnostics Corporation paid the most, $19.

Dr. Acker graduated from Frederick P. Whiddon College of Medicine in 1994. Dr. Acker is a member of AOA, AAD and American Society of Dermatopathology.

Dr. Acker is in network with 10 carriers, including Excellus BlueCross BlueShield, Blue Cross Blue Shield of Michigan and Elevance. Medicaid plans come from the most carriers, 4. Check the plan with the practice before a visit.